- Home
- AYTU vs CTCX Comparison
AYTU vs CTCX Comparison
Compare AYTU & CTCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- CTCX
- Stock Information
- Founded
- AYTU N/A
- CTCX 2007
- Country
- AYTU United States
- CTCX United States
- Employees
- AYTU N/A
- CTCX N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- CTCX Medical/Dental Instruments
- Sector
- AYTU Health Care
- CTCX Health Care
- Exchange
- AYTU Nasdaq
- CTCX Nasdaq
- Market Cap
- AYTU 10.7M
- CTCX 10.4M
- IPO Year
- AYTU N/A
- CTCX N/A
- Fundamental
- Price
- AYTU $1.51
- CTCX $0.25
- Analyst Decision
- AYTU
- CTCX
- Analyst Count
- AYTU 0
- CTCX 0
- Target Price
- AYTU N/A
- CTCX N/A
- AVG Volume (30 Days)
- AYTU 45.2K
- CTCX 616.4K
- Earning Date
- AYTU 11-13-2024
- CTCX 11-14-2024
- Dividend Yield
- AYTU N/A
- CTCX N/A
- EPS Growth
- AYTU N/A
- CTCX N/A
- EPS
- AYTU N/A
- CTCX N/A
- Revenue
- AYTU $79,759,000.00
- CTCX $32,839.00
- Revenue This Year
- AYTU N/A
- CTCX N/A
- Revenue Next Year
- AYTU $2.35
- CTCX N/A
- P/E Ratio
- AYTU N/A
- CTCX N/A
- Revenue Growth
- AYTU N/A
- CTCX N/A
- 52 Week Low
- AYTU $1.41
- CTCX $0.20
- 52 Week High
- AYTU $3.45
- CTCX $4.31
- Technical
- Relative Strength Index (RSI)
- AYTU 26.32
- CTCX 38.67
- Support Level
- AYTU $1.41
- CTCX $0.21
- Resistance Level
- AYTU $1.63
- CTCX $0.26
- Average True Range (ATR)
- AYTU 0.21
- CTCX 0.04
- MACD
- AYTU -0.01
- CTCX 0.00
- Stochastic Oscillator
- AYTU 11.98
- CTCX 26.15
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About CTCX Carmell Corporation
Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.